Gut microbiome (GMB) biomarkers in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) with homologous recombination repair alterations (HRRm) treated with PARP inhibitor (PARPi) therapy.

Steven Yip, Pinaki Bose, Amanda Williams Gibson et al.|Journal of Clinical Oncology|2026

Cited by 0